Cargando…
Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
BACKGROUND: The currently available immunotherapies already changed the strategy how many cancers are treated from first to last line. Understanding even the most complex heterogeneity in tumor tissue and mapping the spatial cartography of the tumor immunity allows the best and optimized selection o...
Autores principales: | Huss, Ralf, Raffler, Johannes, Märkl, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363837/ https://www.ncbi.nlm.nih.gov/pubmed/36813293 http://dx.doi.org/10.1002/cnr2.1796 |
Ejemplares similares
-
Artificial intelligence, molecular subtyping, biomarkers, and precision oncology
por: Shen, John Paul
Publicado: (2021) -
Artificial intelligence for the next generation of precision oncology
por: Ballester, Pedro J., et al.
Publicado: (2021) -
Artificial intelligence for precision oncology: beyond patient stratification
por: Azuaje, Francisco
Publicado: (2019) -
Integration of artificial intelligence and precision oncology in Latin America
por: Sussman, Liliana, et al.
Publicado: (2022) -
Corrigendum to Artificial Intelligence in the Era of Precision
Oncological Imaging
Publicado: (2023)